Frontlight ResearchEarly access
Not yet taking people in SwedenPhase 1
Scan tracer 68Ga-ATH001 in lungs of healthy people and people with scleroderma lung disease
Tests a PET scan tracer in healthy adults and adults with SSc-ILD.
Key facts
- Who runs it
- Antaros Medical AB
- Where
- Uppsala, SwedenSee the 2 sites
- Trial code
- Registry title
- Exploratory, non-randomized, 3-group, microdosing clinical trial to investigate Gallium-68 (68Ga) labeled Platelet-Derived Growth Factor Beta (PDGFRß) targeting Positron Emission Tomography (PET) tracer (68Ga-ATH001) binding in the lungs in healthy participants versus participants with Systemic Sclerosis-associated Interstitial Lung Disease (SSc-ILD)
- Status
- Not yet recruiting
- Phase
- Phase 1
- People taking part
- 15 people, planned
- Started
- 1 Apr 2026
- Expected to end
- 31 Mar 2027
- Type of study
- Interventional
- Record updated
- 11 March 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for healthy adults and adults with systemic sclerosis-associated interstitial lung disease (SSc-ILD). It studies how a PET scan tracer called 68Ga-ATH001 binds in the lungs.
- Age
- 18 years or older
- Sex
- All sexes can join.
- Disease stage
- Adults with systemic sclerosis-associated interstitial lung disease (SSc-ILD), and healthy participants for comparison. The record gives no stage or severity.
Where in Sweden
- CTC Clinical Trial Consultants ABUppsala, SwedenNot yet recruiting
- Uppsala University HospitalUppsala, SwedenNot yet recruiting
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record
Print a page for my doctorSaves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on the EU's official list of trials (CTIS).How to verify a trial in the registry
- Plain-language title
- Scan tracer 68Ga-ATH001 in lungs of healthy people and people with scleroderma lung diseaseGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 9 November 2026.
- Record updated
- 11 March 2026